scholarly article | Q13442814 |
P50 | author | Joseph B. McCormick | Q6281236 |
P2093 | author name string | D. R. Hicks | |
J. P. Getchell | |||
S. W. Mitchell | |||
P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
Acquired immune deficiency syndrome in the United States: the first 1,000 cases | Q34264271 | ||
Acquired immunodeficiency syndrome in a heterosexual population in Zaire | Q39357879 | ||
The broad spectrum antiviral agent ribavirin inhibits capping of mRNA | Q40257383 | ||
Ribavirin small-particle aerosol treatment of influenza | Q40850389 | ||
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides | Q42232008 | ||
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study | Q44603480 | ||
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS | Q44866062 | ||
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results | Q45041492 | ||
Lymphadenopathy Associated Virus Infection of a Blood Donor—Recipient Pair with Acquired Immunodeficiency Syndrome | Q45796469 | ||
P433 | issue | 8416 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ribavirin | Q421862 |
clinical research | Q5133849 | ||
P304 | page(s) | 1367-1369 | |
P577 | publication date | 1984-12-01 | |
1984-12-15 | |||
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes | |
P478 | volume | 2 |
Q24609215 | 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro |
Q34728008 | A guide to the investigation and treatment of patients with AIDS and AIDS-related disorders |
Q42364568 | AIDS and taurolin |
Q39755536 | Acquired immunodeficiency syndrome of childhood |
Q69857527 | Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome |
Q44036228 | Antiretroviral therapy and immunologic reconstitution in AIDS. |
Q39479188 | Antiviral drugs for AIDS. Current status and future prospects |
Q55243682 | Antiviral strategies and vaccines against HTLV III/LAV. |
Q39152916 | Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date |
Q38709585 | Antiviral therapy in human immunodeficiency virus infection |
Q36070394 | Antiviral therapy: current concepts and practices |
Q30047670 | Chemotherapeutics |
Q36787397 | Clinical presentation and management of suspected ribavirin toxicosis in a dog |
Q39659099 | Clinical review of ribavirin. |
Q34104620 | Cyclosporine-induced deterioration in patients with AIDS. |
Q28338199 | Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells |
Q36867854 | Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli |
Q45752014 | Hepatitis C in the patient with human immunodeficiency virus infection |
Q40104175 | Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication. |
Q53548434 | In search of specific inhibitors of retrovirus replication. |
Q36215117 | In vitro and in vivo effects of ribavirin on human respiratory epithelium |
Q37408000 | In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon |
Q28336184 | Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate |
Q39851761 | Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro |
Q28360374 | Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides |
Q24619823 | Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus |
Q39758125 | Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects |
Q28360109 | Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent |
Q41578932 | Metabolism and mode of selective inhibition of human immunodeficiency virus replication by 3'-azido-2',3'-dideoxy-5-iodouridine and 3'-azido-2',3'-dideoxy-5-bromouridine |
Q27486816 | Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796 |
Q39692591 | Pathogenesis of human immunodeficiency virus infection and prospects for control |
Q35289449 | Pharmacokinetics of ribavirin aerosol in mice |
Q55245135 | Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. |
Q36008885 | Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications |
Q28361577 | Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro |
Q28337829 | Ribavirin antagonizes the effect of azidothymidine on HIV replication |
Q50590208 | Ribavirin for HIV |
Q39505179 | Ribavirin: a clinical overview |
Q35810419 | Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection |
Q38172146 | Strategies for antiviral therapy in AIDS. |
Q28340298 | Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine |
Q28338307 | Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro |
Q39563538 | The future of antiviral chemotherapy |
Q28344154 | The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels |
Q33493051 | Toxicologic effects of ribavirin in cats |
Q33740357 | Treatment of human immunodeficiency virus infections |
Q38163930 | Treatment of the acquired immune deficiency syndrome |
Q43848549 | Unique T-cell immune abnormalities in the development of acquired immune deficiency syndrome (AIDS). |
Q24676814 | Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides |
Q55245082 | [AIDS and HTLV-III in West Germany: the status February 1985]. |
Search more.